APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Arterial Hypertension Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pulmonary Arterial Hypertension Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025181 pages

Choose your research edition.

Industry ResearchPulmonary Arterial Hypertension Treatment Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Arterial Hypertension Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Pulmonary Arterial Hypertension Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Arterial Hypertension Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Arterial Hypertension Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pulmonary Arterial Hypertension Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pulmonary Arterial Hypertension Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pulmonary Arterial Hypertension Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Arterial Hypertension Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pulmonary Arterial Hypertension Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmonary Arterial Hypertension Treatment include GSK, Teva Pharmaceuticals Inc, Eli Lilly and Company, Pfizer Inc, Bayer AG, United Therapeutic Corporation, SteadyMed Ltd, Gilead Sciences, Inc and Actelion Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pulmonary Arterial Hypertension Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Arterial Hypertension Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Arterial Hypertension Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pulmonary Arterial Hypertension Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Arterial Hypertension Treatment Segment by Company

GSK

Teva Pharmaceuticals Inc

Eli Lilly and Company

Pfizer Inc

Bayer AG

United Therapeutic Corporation

SteadyMed Ltd

Gilead Sciences, Inc

Actelion Inc

Pulmonary Arterial Hypertension Treatment Segment by Type

Vasodilators

Endothelin Receptor Antagonists (ERA)

Phosphodiesterase 5 (PDE 5) Inhibitors

Soluble Guanylate Cyclase (SGC) Stimulator

Pulmonary Arterial Hypertension Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Pulmonary Arterial Hypertension Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Arterial Hypertension Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Arterial Hypertension Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Arterial Hypertension Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pulmonary Arterial Hypertension Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pulmonary Arterial Hypertension Treatment industry.

Chapter 3: Detailed analysis of Pulmonary Arterial Hypertension Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Arterial Hypertension Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Vasodilators Table 3. Key Players of Endothelin Receptor Antagonists (ERA) Table 4. Key Players of Phosphodiesterase 5 (PDE 5) Inhibitors Table 3. Key Players of Soluble Guanylate Cyclase (SGC) Stimulator Table 4. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pulmonary Arterial Hypertension Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pulmonary Arterial Hypertension Treatment Market Share by Region (2021-2026) Table 11. Global Pulmonary Arterial Hypertension Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pulmonary Arterial Hypertension Treatment Market Share by Region (2027-2032) Table 13. Pulmonary Arterial Hypertension Treatment Industry Trends Table 14. Pulmonary Arterial Hypertension Treatment Industry Drivers Table 15. Pulmonary Arterial Hypertension Treatment Industry Opportunities and Challenges Table 16. Pulmonary Arterial Hypertension Treatment Industry Restraints Table 17. Global Pulmonary Arterial Hypertension Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Pulmonary Arterial Hypertension Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pulmonary Arterial Hypertension Treatment Key Company Head Office and Area Served Table 21. Global Pulmonary Arterial Hypertension Treatment Company, Product Type & Application Table 22. Global Pulmonary Arterial Hypertension Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pulmonary Arterial Hypertension Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pulmonary Arterial Hypertension Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Pulmonary Arterial Hypertension Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2027-2032) Table 35. GSK Company Information Table 36. GSK Business Overview Table 37. GSK Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. GSK Pulmonary Arterial Hypertension Treatment Product Portfolio Table 39. GSK Recent Development Table 40. Teva Pharmaceuticals Inc Company Information Table 41. Teva Pharmaceuticals Inc Business Overview Table 42. Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Product Portfolio Table 44. Teva Pharmaceuticals Inc Recent Development Table 45. Eli Lilly and Company Company Information Table 46. Eli Lilly and Company Business Overview Table 47. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Product Portfolio Table 49. Eli Lilly and Company Recent Development Table 50. Pfizer Inc Company Information Table 51. Pfizer Inc Business Overview Table 52. Pfizer Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Inc Pulmonary Arterial Hypertension Treatment Product Portfolio Table 54. Pfizer Inc Recent Development Table 55. Bayer AG Company Information Table 56. Bayer AG Business Overview Table 57. Bayer AG Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bayer AG Pulmonary Arterial Hypertension Treatment Product Portfolio Table 59. Bayer AG Recent Development Table 60. United Therapeutic Corporation Company Information Table 61. United Therapeutic Corporation Business Overview Table 62. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Product Portfolio Table 64. United Therapeutic Corporation Recent Development Table 65. SteadyMed Ltd Company Information Table 66. SteadyMed Ltd Business Overview Table 67. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Product Portfolio Table 69. SteadyMed Ltd Recent Development Table 70. Gilead Sciences, Inc Company Information Table 71. Gilead Sciences, Inc Business Overview Table 72. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Product Portfolio Table 74. Gilead Sciences, Inc Recent Development Table 75. Actelion Inc Company Information Table 76. Actelion Inc Business Overview Table 77. Actelion Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Actelion Inc Pulmonary Arterial Hypertension Treatment Product Portfolio Table 79. Actelion Inc Recent Development Table 80. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026) Table 86. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032) Table 87. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026) Table 93. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032) Table 94. China Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 95. China Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 96. China Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 97. China Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026) Table 104. Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Pulmonary Arterial Hypertension Treatment Product Image Figure 2. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pulmonary Arterial Hypertension Treatment Market Share by Type: 2025 VS 2032 Figure 4. Vasodilators Image Figure 5. Endothelin Receptor Antagonists (ERA) Image Figure 6. Phosphodiesterase 5 (PDE 5) Inhibitors Image Figure 7. Soluble Guanylate Cyclase (SGC) Stimulator Image Figure 8. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2025 VS 2032 Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Pulmonary Arterial Hypertension Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pulmonary Arterial Hypertension Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pulmonary Arterial Hypertension Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032) Figure 26. North America Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032) Figure 27. North America Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032) Figure 28. United States Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032) Figure 33. Europe Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032) Figure 34. Europe Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032) Figure 35. Germany Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032) Figure 43. China Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032) Figure 44. Asia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032) Figure 46. Asia Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032) Figure 47. Asia Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032) Figure 48. Japan Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032) Figure 58. Brazil Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pulmonary Arterial Hypertension Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Vasodilators
  • Endothelin Receptor Antagonists (ERA)
  • Phosphodiesterase 5 (PDE 5) Inhibitors
  • Soluble Guanylate Cyclase (SGC) Stimulator
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • GSK
  • Teva Pharmaceuticals Inc
  • Eli Lilly and Company
  • Pfizer Inc
  • Bayer AG
  • United Therapeutic Corporation
  • SteadyMed Ltd
  • Gilead Sciences, Inc
  • Actelion Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Vasodilators
  5. 1.2.3 Endothelin Receptor Antagonists (ERA)
  6. 1.2.4 Phosphodiesterase 5 (PDE 5) Inhibitors
  7. 1.2.5 Soluble Guanylate Cyclase (SGC) Stimulator
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pulmonary Arterial Hypertension Treatment Growth Trends by Region
  15. 1.5.1 Global Pulmonary Arterial Hypertension Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pulmonary Arterial Hypertension Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Pulmonary Arterial Hypertension Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pulmonary Arterial Hypertension Treatment Market Dynamics
  1. 2.1 Pulmonary Arterial Hypertension Treatment Industry Trends
  2. 2.2 Pulmonary Arterial Hypertension Treatment Industry Drivers
  3. 2.3 Pulmonary Arterial Hypertension Treatment Industry Opportunities and Challenges
  4. 2.4 Pulmonary Arterial Hypertension Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pulmonary Arterial Hypertension Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Pulmonary Arterial Hypertension Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pulmonary Arterial Hypertension Treatment Key Company Head office and Area Served
  4. 3.4 Global Pulmonary Arterial Hypertension Treatment Company, Product Type & Application
  5. 3.5 Global Pulmonary Arterial Hypertension Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pulmonary Arterial Hypertension Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pulmonary Arterial Hypertension Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pulmonary Arterial Hypertension Treatment Tier 1, Tier 2, and Tier 3
4 Pulmonary Arterial Hypertension Treatment Market by Type
  1. 4.1 Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Pulmonary Arterial Hypertension Treatment Market Size Share by Type (2021-2032)
5 Pulmonary Arterial Hypertension Treatment Market by Application
  1. 5.1 Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Pulmonary Arterial Hypertension Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GSK Pulmonary Arterial Hypertension Treatment Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Teva Pharmaceuticals Inc
  8. 6.2.1 Teva Pharmaceuticals Inc Company Information
  9. 6.2.2 Teva Pharmaceuticals Inc Business Overview
  10. 6.2.3 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Inc Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Pfizer Inc
  20. 6.4.1 Pfizer Inc Company Information
  21. 6.4.2 Pfizer Inc Business Overview
  22. 6.4.3 Pfizer Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc Pulmonary Arterial Hypertension Treatment Product Portfolio
  24. 6.4.5 Pfizer Inc Recent Developments
  25. 6.5 Bayer AG
  26. 6.5.1 Bayer AG Company Information
  27. 6.5.2 Bayer AG Business Overview
  28. 6.5.3 Bayer AG Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer AG Pulmonary Arterial Hypertension Treatment Product Portfolio
  30. 6.5.5 Bayer AG Recent Developments
  31. 6.6 United Therapeutic Corporation
  32. 6.6.1 United Therapeutic Corporation Company Information
  33. 6.6.2 United Therapeutic Corporation Business Overview
  34. 6.6.3 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Product Portfolio
  36. 6.6.5 United Therapeutic Corporation Recent Developments
  37. 6.7 SteadyMed Ltd
  38. 6.7.1 SteadyMed Ltd Company Information
  39. 6.7.2 SteadyMed Ltd Business Overview
  40. 6.7.3 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Product Portfolio
  42. 6.7.5 SteadyMed Ltd Recent Developments
  43. 6.8 Gilead Sciences, Inc
  44. 6.8.1 Gilead Sciences, Inc Company Information
  45. 6.8.2 Gilead Sciences, Inc Business Overview
  46. 6.8.3 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Product Portfolio
  48. 6.8.5 Gilead Sciences, Inc Recent Developments
  49. 6.9 Actelion Inc
  50. 6.9.1 Actelion Inc Company Information
  51. 6.9.2 Actelion Inc Business Overview
  52. 6.9.3 Actelion Inc Pulmonary Arterial Hypertension Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Actelion Inc Pulmonary Arterial Hypertension Treatment Product Portfolio
  54. 6.9.5 Actelion Inc Recent Developments
7 North America
  1. 7.1 North America Pulmonary Arterial Hypertension Treatment Market Size (2021-2032)
  2. 7.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type
  3. 7.2.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application
  7. 7.3.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Pulmonary Arterial Hypertension Treatment Market Size by Country
  11. 7.4.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pulmonary Arterial Hypertension Treatment Market Size (2021-2032)
  2. 8.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type
  3. 8.2.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application
  7. 8.3.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country
  11. 8.4.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pulmonary Arterial Hypertension Treatment Market Size (2021-2032)
  2. 9.2 China Pulmonary Arterial Hypertension Treatment Market Size by Type
  3. 9.2.1 China Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032)
  6. 9.3 China Pulmonary Arterial Hypertension Treatment Market Size by Application
  7. 9.3.1 China Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pulmonary Arterial Hypertension Treatment Market Size (2021-2032)
  2. 10.2 Asia Pulmonary Arterial Hypertension Treatment Market Size by Type
  3. 10.2.1 Asia Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Pulmonary Arterial Hypertension Treatment Market Size by Application
  7. 10.3.1 Asia Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Pulmonary Arterial Hypertension Treatment Market Size by Country
  11. 10.4.1 Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst